Rationale Orbital/insular areas of the prefrontal cortex (PFC) are implicated in cocaine addiction. However, the role of dopamine D 1 receptors in mediating cocaine selfadministration in these sub-regions remains unknown. Objectives To define the role of the dorsal agranular insular (AId) sub-region of the PFC, we investigated the effects of D 1 receptor manipulation on self-administration behavior maintained by cocaine and cocaine-related stimuli. Materials and methods Rats were trained to lever press for cocaine (1 mg/kg) under a fixed-interval 5-min (fixed-ratio 5: S) second-order schedule of reinforcement in the presence of conditioned light cues and contextual sound cues. Intra-AId infusions of vehicle, the D 1 -like receptor agonist SKF 81297 (0.1, 0.2, 0.4 μg/side) or the D 1 -like receptor antagonist SCH 23390 (1.0, 2.0, 4.0 μg/side), were administered prior to 1-h self-administration test sessions. Food-maintained responding under a second-order schedule was examined in separate rats to determine if pretreatment with D 1 ligands produced general impairments in responding. Results Infusion of SKF 81297 (0.2 and 0.4 μg/side) reduced active lever responses during the first 30 min of 1-h test sessions, but did not influence cocaine intake. Infusion of 4.0 μg/side SCH 23390 reduced active lever responses and cocaine intake throughout the 1-h test sessions. Additionally, this dose of SCH 23390 disrupted food-maintained responding and intake.
Introduction
Several studies using animal models of drug addiction have reported changes in responding elicited by cocaine and/or cocaine-related stimuli following systemic administration of dopamine receptor agonists and antagonists (Self et al. 1996; Weissenborn et al. 1996; Caine et al. 1999; Khroyan et al. 2000 Khroyan et al. , 2003 Alleweireldt et al. 2002 Alleweireldt et al. , 2003 Crombag et al. 2002; Olsen and Duvauchelle 2006) . Interestingly, systemic injections of D 1 -like receptor agonists or antagonists produce similar, rather than opposing, dose-dependent reductions in responding maintained by cocaine during cocaine selfadministration sessions (Caine et al. 2000; Platt et al. 2001; Mutschler and Bergman 2002; Barrett et al. 2004) , suggesting an important inhibitory role for D 1 receptors in mediating cocaine self-administration. However, studies involving intra-cranial infusions of D 1 ligands indicate that the effects of D 1 receptor manipulations during cocaine self-administration are more complex. For instance, D 1 receptor antagonism in the nucleus accumbens (NAc) shell with SCH 23390 (1.0 μg/side) attenuates cocaine-induced reinstatement (Anderson et al. 2003) , whereas administration of the D 1 -like receptor agonist SKF 81297 (1.0 μg/side) reinstates drug-seeking behavior (Bachtell et al. 2005; Schmidt et al. 2006) . Moreover, infusion of SCH 23390 (2.0 μg/side) into the caudal basolateral amygdala (BLA) has been shown to increase the number of infusions earned during cocaine selfadministration sessions, whereas infusion into the rostral BLA (2.0 μg/side) fails to alter this behavior, but attenuates cue-and cocaine-induced reinstatement of drug-seeking behavior (Alleweireldt et al. 2006) .
Given these contrasting findings, it is clear that D 1 receptors in the amygdala and NAc mediate cocaine consumption and the motivating influence of cocaine-related stimuli in different ways and in manners that are dependent on specific sub-regions within these brain sites. Another important brain area implicated in drug-seeking behavior is the prefrontal cortex (PFC; Weissenborn et al. 1997; McFarland and Kalivas 2001; McLaughlin and See 2003; Fuchs et al. 2004 Fuchs et al. , 2005 . Previous studies have shown that rats will intra-cranially self-administer cocaine into the medial PFC (Goeders and Smith 1983; ) and that DA manipulation in this brain region via 6-hydroxydopamine lesions or D 2 receptor antagonism prevents intra-cranial cocaine-maintained responding . Moreover, similar to systemic administration of D 1 ligands, D 1 -like receptor antagonism in the medial PFC with low to intermediate doses of SCH 23390 (0.1-2.0 μg/side) is sufficient to block the reinstatement of cocaine-induced drug-seeking behavior (Sun and Rebec 2005) and cocaine-conditioned place preference (Sanchez et al. 2003) . Lastly, stimulation of medial PFC D 1 receptors with 0.1 μg/side SKF 81297 has been demonstrated to block the expression of cocaine sensitization (Sorg et al. 2001) . Thus, similar to D 1 receptors in the shell region of the NAc and in the rostral portion of the amygdala, these findings suggest that D 1 receptors in the medial PFC are also critical for mediating drug-seeking behavior induced by cocaine priming injections or by presentations of cocaine-conditioned cues.
However, given that the PFC is comprised of numerous anatomically and functionally distinct sub-regions, the role of D 1 receptors located in other prefrontal sub-regions, such as in orbital and insular cortices, in mediating cocaine selfadministration remains unknown and must be investigated as well. Recent work from our laboratory has shown that the working memory functions of rodent orbital/agranular insular cortex are particularly sensitive to the effects of selfadministered cocaine (Kantak et al. 2005) . Therefore, the current study examined the effects of infusing the D 1 -like receptor antagonist SCH 23390 or the full D 1 -like receptor agonist SKF 81297 into the dorsal agranular insular (AId) sub-region of the PFC in rats trained to self-administer cocaine under a second-order schedule of reinforcement (see Fig. 1 for a timeline of the cocaine self-administration protocol). The second-order schedule was chosen because it is particularly useful for ascertaining the neural systems important for maintaining cocaine self-administration and the motivating influence of cocaine-related stimuli (Weissenborn et al. 1997; Arroyo et al. 1998; Everitt and Robbins 2000; Kantak et al. 2002a; Schindler et al. 2002) .
Materials and methods
Subjects and apparatus Twenty Crl(WI)BR rats (Wistar strain, Charles River Breeding Labs, Portage, MI, USA), weighing approximately 275 g upon arrival, were maintained at 85% of an adjusted ad libitum body weight throughout the duration of the study by restricting food to approximately 16 g per day. Between experimental sessions, the rats had unlimited access to water in their home cages. Rats were housed in individual clear plastic cages (24 cm×22 cm× 20 cm) in a temperature-(21-23°C) and light-(08:00 h on, 20:00 h off) controlled vivarium. Eight experimental chambers (model ENV-008CT; Med Associates, Georgia, VT, Fig. 1 Diagram depicting the timeline for the cocaine self-administration protocol USA), as previously described in detail (Kantak et al. 2002a, b) , were used. Motor-driven syringe pumps (Model PHM-100, Med Associates, Georgia, VT, USA) located outside of each experimental chamber were used for drug delivery. A different model syringe pump (Orion/Sage, Model 341A, Boston, MA, USA) was used for intracerebral infusions. The policies and procedures set forth in the "Guidelines for the Care and Use of Mammals in Neuroscience and Behavioral Research" were followed, as well as specific national laws. The Boston University Institutional Animal Care and Use Committee approved these studies.
Drugs
The drugs used in this study were cocaine hydrochloride (gift from NIDA, Bethesda, MD, USA), (+)-SKF 81297 hydrobromide and (+)-SCH 23390 hydrochloride. The D 1 ligands were both purchased from Sigma (St. Louis, MO, USA). Cocaine was dissolved in sterile 0.9% saline solution containing 3 IU heparin/ml up to a final concentration of 2.68 mg/ml. For all self-administration experiments, a 1.0-mg/kg unit infusion dose of cocaine was used and delivered intravenously at a rate of 1.8 ml/min. To attain a dose of 1.0 mg/kg, infusion volume was adjusted for body weight, resulting in drug delivery times of 1.2 s/100 g body weight in individual rats. During saline self-administration sessions, heparinized saline solution was substituted for cocaine. SCH 23390 was dissolved in sterile 0.9% saline and the solution was made fresh on testing days immediately before intra-cranial infusions took place. A stock solution was made using 5 mg SKF 81297 dissolved in 3.125 ml of sterile 0.9% saline (0.8 μg/0.5 μl, salt weight). Lower concentrations were made via serial dilution. Sterile 0.9% saline was used as the control vehicle for SKF 81297 and SCH 23390. The pH of all solutions, including the sterile 0.9% saline solution used as the vehicle control, was 4.0.
Surgery and histology procedures Guide cannulae were stereotaxically implanted into the agranular insular area (AP +2.8, L+4.5, DV−5.8) of the PFC as detailed in Di Pietro et al. (2004) . For intravenous delivery of cocaine or saline during self-administration sessions, surgical implant of jugular vein catheters was performed as previously described in detail (Kantak et al. 2000 ). Children's tylenol in drinking water (5 ml/250 ml water) and subcutaneously administered buprenorphine (0.05 mg/kg) were provided to manage postsurgical pain and discomfort for 48 h. Rats were also injected subcutaneously with the antibiotic Baytril (15 mg/kg) for 5 days post-surgery to reduce the risk of infection. Catheters were checked for function weekly by infusing a 0.1-ml solution containing 1 mg methohexital sodium (Brevital; King Pharmaceuticals, Inc, Bristol, TN, USA) and noting the presence or absence of sedation. A new catheter was implanted into either the left jugular vein or right femoral vein as needed to replace leaking or non-functional catheters. All rats were allowed to recover from surgery for 1 week before initiation of the experiments. Wounds were treated daily with nitrofurazone powder until healed. Catheters were maintained by flushing them daily (Monday through Friday) with 0.1 ml of a 0.9%-saline solution containing 0.3 IU heparin (LymphoMed, Rosemont, IL, USA) and 6.7 mg timentin (Smith Kline Beecham Pharmaceuticals, Philadelphia, PA, USA). On Fridays, a locking solution consisting of glycerol and undiluted heparin (3:1) was used to fill the catheter dead space. This solution remained in the catheters over the weekend and it was removed and replaced with the diluted saline/heparin solution on Mondays prior to the start of the behavioral sessions.
Upon completion of the experiments, rats were given an overdose of sodium pentobarbital and then intracardially perfused with saline and 10% formalin solution. Brains were removed, post-fixed in 10% formalin for 4 h, and then stored in 30% sucrose at 4°C overnight. Coronal sections that were 50 μm thick were collected using a freezing microtome. Sections were then mounted on gelatin-coated slides, stained with thionin to verify cannula placements, dried, and dehydrated before cover slipping.
Microinfusion procedure Rats received bilateral infusions of drug or vehicle into the AId immediately before each test session. Prior to intra-cranial infusions, dummy cannulae were removed and infusions of 0.5 μl/side were administered through 28-gauge injection cannulae connected to a 5-μl syringe via PE 20 tubing. Injection cannulae extended 1 mm beyond the tip of the guide and infusions took place over a 90-s period. Infusion of the drug was confirmed by movement of a small air bubble in the PE 20 tubing a fixed distance. Injection cannulae were left in place for 60 s to allow for diffusion into brain tissue before removal, and then dummy cannulae were replaced. Each intra-AId infusion was separated by a minimum of 2 days of training to re-establish baseline performance. Animals received a maximum of eight intra-cranial infusions to avoid tissue damage at the injection site. Previous studies demonstrated that the number of sessions to acquire a non-spatial working memory task requiring the intact functioning of the AId did not differ between control rats receiving daily infusions of vehicle into the AId (11 sessions; Di Pietro et al. 2004) vs. no treatment (ten sessions; Kantak et al. 2005) . Thus, it is highly likely that the functional integrity of the AId was preserved following the eight AId infusions used in the present study.
Self-administration procedures
Training for drug-maintained responding Before surgery, rats (n=12) were trained to respond on a lever for food reinforcement under a fixed-ratio 1 (FR 1) schedule of food pellet delivery. Once rats learned to press for 100 food pellets in less than 30 min, right jugular vein catheters and guide cannulae were implanted. One week later, self-administration training began. Initial sessions were 2 h in duration. Rats were incrementally trained to self-administer 1.0 mg/kg cocaine under a terminal fixed-interval (FI)-based second-order schedule of drug delivery that incorporated contextual sound and conditioned light stimuli. For half of the rats in each group, the right lever was designated as the active lever, and for the other half, the left lever was designated as the active lever. Delivery of cocaine was contingent on the completion of five responses on the active lever after the 5-min FI elapsed. The light stimulus over the active lever remained illuminated for the duration of the infusion and during a 20-s timeout (TO) period that followed each infusion. The TO period was signaled by extinguishing the house light. During the FI, a 2-s brief stimulus light was presented after every fifth response on the active lever. For half the rats, the contextual sound cue consisted of an intermittent tone (70 db; 7 kHz; 0.5 s duration every second) and for the other half a continuous white noise (70 db). The contextual cue was presented throughout the duration of 2-h training sessions. Training sessions were conducted 5 days a week during the light phase and continued until cocaine intake was stable (number of infusions did not deviate by more than 20%), and the number of responses on the inactive lever was no greater than 25 per session for a 5-day period.
Training for food-maintained responding A separate group of animals (n=8) were bilaterally implanted with cannulae into the AId and trained to lever press for 45 mg chocolateflavored purified food pellets (Bio-Serv, Frenchtown, NJ, USA) under the FI5(FR5:S) second-order schedule during daily (Monday-Friday) 1-h sessions. Second-order schedule training procedures for these rats were the same as described in the section above with the exception that food pellets rather than cocaine were used as the reinforcer. A single 45 mg food pellet was delivered upon completing the FR5 response requirement after each 5-min FI elapsed.
Experimental design
Drug maintenance testing To ensure that the cocaine cues were highly salient, against which the effects of SCH 23390 and SFK 81297 were tested, rats were given daily saline selfadministration sessions with a unique set of light and sound cues in addition to daily cocaine self-administration sessions. Discrimination training procedures were implemented according to the methods outlined in Kantak et al. (2002a, b) after baseline cocaine self-administration under the second-order schedule was acquired. Briefly, rats were given ten discrimination sessions consisting of two (saline and cocaine) 1-h sessions, separated by 1-h. The order in which saline and cocaine sessions were conducted was counterbalanced for each rat. During cocaine and saline sessions, a unique discriminative contextual auditory stimulus (intermittent tone or continuous white noise) was presented and counterbalanced for each condition. In addition, to provide a unique conditioned light stimulus for saline sessions, the stimulus light present over the active lever flashed, instead of remaining constant as in cocaine sessions, during presentation of the brief stimulus, drug infusion, and TO period. Discrimination training took place 5 days per week.
Rats were then tested for the effects of intra-cranial infusions of SCH 23390 or SKF 81297 within the AId of the PFC on lever responding and cocaine intake maintained by an FI 5-min (FR5:S) schedule that utilized the cocaineassociated sound and light cues. One subset of rats was tested first with SCH 23390 and then with SKF 81297, and another subset of rats was tested first with SKF 81297 and then with SCH 23390. Bilateral infusions of vehicle (0 μg control) or the D 1 -like receptor antagonist SCH 23390 (1.0, 2.0, and 4.0 μg/side, salt weight) or the D 1 -like receptor agonist SFK 81297 (0.1, 0.2, 0.4 μg/side, salt weight) were given into the AId of rats immediately prior to maintenance testing sessions. Once maintenance testing with the D 1 antagonist or agonist was complete, the same group of animals was given 3 days to re-establish baseline responding before maintenance testing with vehicle and the other D 1 -like ligand began. One-hour saline self-administration sessions were not conducted on cocaine maintenance test days. The doses of SCH 23390 and SKF 81297 that were chosen for this study were infused in an irregular order in individual animals and were based on the range of doses used in other studies (Zahrt et al. 1997; Floresco and Phillips 2001; See et al. 2001; Anderson et al. 2003; Schmidt et al. 2006) . Throughout the study, testing was conducted every third day, with discrimination sessions on intervening days.
Food maintenance testing It has been shown that following a systemic injection of cocaine (10 mg/kg i.p.) and an intra-cranial infusion of 1.0 μg/side SCH 23390 into the accumbens or amygdala, motor inhibition is produced in rats (McGregor and Roberts 1993) . Therefore, to determine if reductions in lever responding following pretreatment with a D 1 -like receptor agonist or antagonist were caused by a general impairment in motor responding, food-maintained responding was investigated. Only the highest doses of SCH 23390 and SKF 81297 that produced the most significant reductions in cocaine-maintained responding were tested. Following second-order schedule training and baseline measurements, vehicle was infused into the AId 5 min before the start of the 1-h food self-administration session (control test session). Infusions of SCH 23390 (4.0 μg/side) or SKF 81297 (0.4 μg/side) were similarly administered 5 min prior to testing in a counterbalanced order. Testing was conducted every 2 to 3 days with 1-h food self-administration sessions given on intervening days.
Data analyses Some rats died or had to be excluded from the study because of short catheter life spans or improper cannulae placements. Therefore, statistical analyses were performed on data from nine of 12 rats in the cocaine selfadministration experiment and from six of eight rats in the food self-administration experiment. For cocaine and food self-administration experiments, three dependent measures were recorded over the course of 1-h maintenance test sessions: (1) the number of active lever responses made; (2) the number of inactive lever responses made (non-specific motor effects); (3) the number of reinforcers earned (cocaine infusions or food pellets). Data over the last five cocaine and saline discrimination sessions and the last five food selfadministration sessions were averaged for individual rats and used as a measure of baseline responding. Averaging the last five sessions captures the day-to-day variation in responding and provides a better representation of an individual animal's baseline rate of responding. For these data, paired t tests were used to determine if rats discriminated between cocaine and saline during drug self-administration baseline sessions and if the baseline rate of responding maintained by food was altered by the vehicle control infusion into the AId. For cocaine maintenance and food maintenance testing, a series of one-way ANOVAs with repeated measures were used to analyze each dependent variable, with each ANOVA comparing vehicle infusions with SCH 23390 and/or SKF 81297 infusions. In addition, given that the time course of the effects of D 1 receptor manipulation has been shown to be greatest at the onset of cocaine self-administration test sessions (Alleweireldt et al. 2006) , the number of active lever responses emitted and infusions earned during the first and last 30 min of each cocaine session was calculated from these dependent measures and similarly analyzed using single-factor ANOVAs with repeated measures. Tukey tests were used for all post hoc comparisons.
Results

Histology
Histological verification of bilateral AId cannulae placements is depicted in Fig. 2 . For the 15 rats used in the data analyses, cannulae were within 0.5 mm of the intended placement in the anterior-posterior plane, within 0.6 mm in the lateral plane, and within 0.4 mm in the dorsal-ventral plane.
Drug maintenance testing
During baseline sessions, cocaine maintained significantly higher levels of active lever responding (Fig. 3a) than saline (t (8)=3.067, p<0.015). Inactive lever responding (Fig. 3a) averaged fewer than ten responses and was not significantly different under saline and cocaine baseline conditions. The number of infusions earned (Fig. 3b ) during baseline cocaine sessions was significantly greater than the number earned during baseline saline sessions (t(8)=7.438; p≤0.001). These data indicate that rats were able to successfully discriminate cocaine from saline and the active lever from the inactive lever prior to maintenance test sessions.
During maintenance test sessions, one-factor repeated measures ANOVA revealed that the number of active lever responses emitted over the course of 1-h, was significantly altered (F(3, 24)=14.646, p<0.001) following infusion of the D 1 -like receptor antagonist SCH 23390 into the AId (Fig. 4a) . Tukey tests showed that active lever responding was significantly less (p<0.05) following infusion with the highest dose of SCH 23390 (4.0 μg/side) compared to 0.0, 1.0, and 2.0 μg/side SCH 23390. In addition, the number of cocaine infusions earned during the 1-h test sessions (Fig. 4b) was significantly altered as well (F(3, 24)= 15.929, p≤0.001). Post-test analyses indicated that cocaine infusions were significantly reduced (p<0.05) following infusion with the 4.0 μg/side dose of SCH 23390 compared to 0.0-2.0-μg/side treatments. Inactive lever responding was not significantly altered following SCH 23390 infusions.
To determine the time course of action of the effects of SCH 23390 on active lever responding, one-factor repeated measures ANOVA during the first and last 30 min of the 1-h test sessions was carried out. These analyses revealed that SCH 23390 reduced active lever responses during the first (F Fig. 2 Representative photomicrograph of the extent of damage made by 22-gauge guide cannulae and the tip location of the 28-gauge infusion cannulae. A schematic representing a coronal section of the rat brain is superimposed on the left hemisphere to indicate the locations of the dorsal agranular insular area (AId). The circle indicates the location of D 1 ligand or vehicle infusions. Guide cannulae were bilaterally positioned 1 mm above the infusion site at a level 2.8 mm anterior to bregma (3, 24)=3.723, p<0.025) and last (F(3, 24)=3.141, p< 0.044) 30 min of the session, suggesting that the overall reductions in active lever responding occurred throughout the 1-h test sessions. Post hoc tests revealed that active lever responses during the first 30 min (Fig. 4a, inset) were attenuated following 4.0 mg/side SCH 23390 as compared to vehicle (p≤0.05). During the last 30 min, infusion with the highest dose of SCH 23390 attenuated active lever responding as compared to infusion with 2.0 mg/side SCH 23390 (p≤0.05). Similar examination of the number of cocaine infusions earned revealed that SCH 23390 significantly altered cocaine intake during the first 30 min (F(3, 24)=9.925, p<0.001) and last 30 min (F(3, 24)=5.733, p≤ 0.004). The highest dose of SCH 23309 produced a significant (p≤0.05) reduction in the number of infusions earned compared to 0.0-2.0 μg/side treatments during the first (Fig. 4b, inset) and last 30 min of 1-h test sessions.
Infusion with the D 1 -like receptor agonist SKF 81297 into the AId did not significantly reduce active lever responding or cocaine intake over the course of the entire 1-h test sessions ( Fig. 5a and b) , nor were inactive lever responses significantly altered following SKF 81297 infusions. However, one-factor repeated measures ANOVA analysis of the first and last 30 min of the 1-h session revealed that SKF 81297 did significantly alter active lever responding during the first 30 min (Fig. 5a, inset ) of the session (F(3, 24)= 6.339, p<0.003). Post-test analyses indicated that active lever responding was significantly attenuated following infusion with 0.2 μg/side (p≤0.05) and 0.4 μg/side (p≤0.05) doses of SKF 81297 as compared to vehicle (0.0 μg/side) during the first 30 min. No significant differences were obtained for active lever responding during the last 30 min. Lastly, similar examination of the number of cocaine infusions earned revealed that cocaine intake was not significantly altered within the first (Fig. 5b, inset) or last 30 min.
Food maintenance testing Paired t tests revealed that baseline levels of active lever responses (477±96), inactive lever responses (39±8) and pellets earned (10±0.1) did not significantly differ from levels measured after vehicle treatment within the AId. One-factor repeated measures ANOVA comparing vehicle to drug treatments revealed that active (F(2, 10)=14.6, p<0.001) and inactive (F(2, 10)= 10.9, p<0.003) lever responding maintained by food was significantly altered as was the number of food pellets earned (F(2, 10)=20.05, p<0.001). Tukey post hoc tests indicated that active lever responses (118 ± 70), inactive lever responses (6±1), and pellets earned (5±1) following infusion with 4.0 μg/side SCH 23390 were significantly attenuated (p<0.05) as compared to vehicle and 0.4 μg/side SKF 81297 treatments, which did not differ statistically. Given that differences in active lever responding were greatest during the first 30 min of 1-h cocaine self-administration sessions after SKF 81297, changes during 1-h food self-administration sessions were also examined during the first and last 30 min. One-factor repeated measures ANOVA comparing vehicle to drug treatments revealed that active lever responding was significantly altered during the first (F(2, 14)=8.3, p<0.004) and last (F(2, 14)=9.7, p<0.002) 30 min of food maintenance test sessions. Additionally, the number of food pellets earned during the first (F(2, 14)=14.6, p< 0.001) and last (F(2, 14)=17.3, p<0.001) 30 min was significantly altered. Tukey post hoc tests indicated that both measures were significantly attenuated (p<0.02) following infusion with 4.0 μg/side SCH 23390, but not 0.4 μg/side SKF 81297, as compared to vehicle treatment during the first and last 30 min of the 1-h sessions (Fig. 6a and b) .
Discussion
Imaging and lesion/inactivation studies (Volkow and Fowler 2000; Porrino et al. 2002; Di Pietro et al. 2004 ; and number of infusions earned (b). *p<0.05 compared to saline for active lever responses and +p<0.05 compared to saline for infusions earned Fuchs et al. 2004 ) have indicated that orbital/insular areas of the PFC might be involved in cocaine addiction. However, the role of DA D 1 receptors in these prefrontal sub-regions in mediating cocaine intake and responding maintained by cocaine and cocaine-related stimuli is unknown. Therefore, intra-AId infusions of the full D 1 -like receptor agonist SKF 81297 or the D 1 -like receptor antagonist SCH 23390 were administered to rats trained to self-administer cocaine under a second-order schedule. Our results showed that while cocaine intake remained unaffected, intra-AId infusions of 0.2 and 0.4 μg/side SKF 81297 reduced active lever responding during the first 30 min of cocaine maintenance test sessions. Moreover, these effects were specific for responding maintained by cocaine and cocaine-related stimuli as infusion of the highest dose of SKF 81297 failed to alter lever responding maintained by food pellets or food consumption that was studied under an identical schedule of reinforcement. These finding are interesting in light of recent evidence showing that infusions of 0.3 and 3.0 μg/side SKF 81297 into the NAc core and shell reinstated extinguished cocaineseeking behavior but did not influence stabilized cocaine intake (Bachtell et al. 2005) . Moreover, the effects of SKF 81297 in the NAc core were more transient than in the shell for facilitating lever responding, peaking at approximately 30 min after the start of reinstatement testing. Together, these data suggest that D 1 receptor activation in the NAc core vs. the AId during test sessions may transiently alter responding in opposing manners while leaving cocaine consumption and food-maintained responding and consumption intact. Consistent with this idea, several studies report opposing influences of DA in the PFC and NAc whereby low extracellular DA levels in the PFC produce hyper-dopaminergic states in the NAc (Thompson and Moss 1995; King et al. 1997 ) and vice versa . Thus, activation of prefrontal AId DA D 1 receptors may lead to a transient decrease in dopaminergic activity in the NAc core, a site believed necessary for drug-seeking behavior (McFarland and Kalivas 2001) . Anatomically, the AId sub-region has been shown to project to the NAc core while avoiding innervation of the shell (Wright and Groenewegen 1996) . Interestingly, stimuli paired with cocaine under a secondorder schedule have been shown to increase extracellular levels of DA in the NAc core, but not the shell, whereas elevation of DA in the NAc shell is greater than in the core during cocaine self-administration (Ito et al. 2000) . This suggests that the action of D 1 receptor stimulation in the AId may be to reduce the motivating influence of cocaine-related stimuli on responding, particularly in light of the fact that SKF 81297 infusion into the AId did not alter cocaine intake in the present study. Previous studies have reported reductions in cocainemaintained responding following systemic injections of D 1 -like receptor agonists (Caine et al. 2000; Platt et al. 2001; Mutschler and Bergman 2002; Barrett et al. 2004 ). The present findings therefore suggest that D 1 receptors in the AId may be an important substrate for mediating the inhibitory effects of systemic administration of D 1 agonists on cocainemaintained responding. It remains uncertain, however, why the inhibitory effects of SKF 81297 are greatest at the onset of cocaine self-administration and then dissipate after 30 min. Further research is needed to elucidate the time course of action of SKF 81297 in the presence of cocaine and/or elevated levels of dopamine in the cortex.
Despite a disruption in lever responding maintained by cocaine and cocaine-related stimuli, cocaine intake was not altered following intra-AId infusions of SKF 81297. Again, these results are consistent with those of Bachtell et al. (2005) showing no disruptions in cocaine intake following infusions with either D 1 or D 2 agonists in the NAc core or shell. Given that rats are self-administering cocaine throughout 1-h test sessions, it is possible that the effects of cocaine on extracellular dopamine levels may override any additional effects of D 1 agonist stimulation in the AId. Thus, activation of D 1 receptors in additional brain sites may be necessary for changes in cocaine intake to occur. Alternatively, blockade of D 1 receptors in the AId may be required to counteract the effects of cocaine-induced increases in extracellular dopamine.
Accordingly, D 1 receptor antagonism in the AId with 4.0 μg/side SCH 23390 was sufficient to reduce the overall magnitude of active lever responding and cocaine intake within the same group of animals. However, given that food-maintained responding and consumption studied under an identical schedule of reinforcement were also significantly attenuated following infusion of 4.0 μg/side SCH 23390, it is likely that these behavioral changes reflect nonspecific disruptions in motor responding similar to those reported by McGregor and Roberts (1993) . Many studies have reported reduced responding maintained by food in monkeys and rats following systemic administrations of D 1 -like receptor agonists and antagonists (Woolverton and Virus 1989; Glowa and Wojnicki 1996; Weissenborn et al. 1996; Caine et al. 2000; Platt et al. 2001) , indicating that the suppression of cocaine self-administration by systemically administered D 1 receptor ligands is non-selective. However, in the study by Bachtell et al. (2005) it was shown that intraNAc infusions of SCH 23390 (3 mg/side) failed to alter sucrose pellet self-administration in rats, suggesting that intra-cranial infusions of a D 1 -like antagonist could overcome global disruptions in motor responding. Unfortunately, intra-cranial infusion with 4 μg/side SCH 23390 in the current study produced significant disruptions in foodmaintained responding and consumption. The disparity between our results and those of Bachtell et al. (2005) for food self-administration likely reflect differences in the type of operant schedule used (FI5(FR5:S) vs. FR1) and the brain region targeted. Moreover, it should be noted that the doses of SCH 23390 used in the current study are quite high and, as pointed out by others (Alleweireldt et al. 2006) , any changes in behavior may reflect interactions with additional receptors in the AId such as 5-HT 2C receptors (Millan et al. 2001 ) and G protein-coupled, inwardly rectifying potassium channels (Kuzhikandathil and Oxford 2002) for which SCH 23390 has an affinity. Given that SCH 23390 is a potent agonist at 5-HT 2C receptors (Millan et al. 2001 ) and that 5-HT 2C agonists have been shown to reduce food-maintained responding in squirrel monkeys (Brady and Barrett 1985; McKearney 1990 ), this may be why infusion of SCH 23390 but not SKF 81297 led to global disruptions in operant responding.
Others have shown that intra-cranial infusion of SCH 23390 within the medial PFC (0.3 μg/side), NAc shell (1.0 μg/side), or BLA (2.0 μg/side) reduces drug-seeking behavior induced by cocaine-associated cues or a priming injection of cocaine (See et al. 2001; Bachtell et al. 2005; Sun and Rebec 2005; Berglind et al. 2006) , whereas infusion into the caudal BLA (2.0 μg/side) or NAc shell (1.0 μg/side) significantly increases the number of cocaine infusions earned during maintenance testing (Alleweireldt et al. 2006; Bachtell et al. 2005) . In the present study, however, intra-AId infusions with similar doses of SCH 23390 (i.e., 1.0 and 2.0 μg/side) did not yield any significant findings. Together with the food-maintenance data, it appears that D 1 receptor inactivation within the AId with behaviorally selective doses (<4.0 μg/side) is insufficient to selectively alter cocaine intake or lever responding under a second-order schedule.
Damage to orbital and insular cortices has been shown to block cue-induced reinstatement of drug-seeking behavior (Fuchs et al. 2004) and to disrupt the incentive value of anticipated reinforcers (Gallagher et al. 1999) . The current data extend these findings to show that D 1 receptors in the AId may help mediate the motivating influence of cocainerelated stimuli used to maintain responding at times when cocaine is not immediately available for self-administration. However, the finding that lever responding was selectively reduced following D 1 receptor stimulation, but not D 1 receptor inactivation, suggests dissociation between the effects of SCH 23390 and SKF 81297 within the AId. Recently, we reported that AId inactivation with the sodium channel blocker lidocaine did not alter responding maintained by cocaine and cocaine-related stimuli or its consumption in rats during 1-h maintenance test sessions, nor did it alter drug-seeking behavior during cocaine primeinduced reinstatement test sessions (Di Pietro et al. 2006 ). However, in that report, intra-AId lidocaine infusions did attenuate reinstatement of drug-seeking behavior following presentation of cocaine-related stimuli alone. Thus, our findings suggest that in the presence of systemic cocaine, AId regulation of responding maintained by cocaine-related stimuli may be particularly sensitive to the effects of increased extracellular dopamine levels and subsequent dopamine receptor activity. Future studies examining the effects of D 1 receptor manipulation on cue-and/or drug-induced reinstatement of drug-seeking behavior are needed to further explore this issue. Taken together, the current study adds to the rapidly growing body of evidence that lateral/orbital PFC sub-regions, in addition to the medial PFC, are key contributors to mediating behaviors related to cocaine addiction.
